| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -3.6e-05 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |